Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.124.1 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.124.1 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.124.1 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.124.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.124.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.124.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GS.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GS.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GS.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GS.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GS.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
CR.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CR.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CR.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BV.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BV.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BV.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BV.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BV.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BV.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.4.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.4.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.4.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.4.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.4.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.4.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.7.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GS.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.7.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GS.7.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GS.7.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GS.7.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GS.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XWEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XWEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XWECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XWECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XWEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XWEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used